Potentially conserved roles of KIAA1109/BLTP1 and other mammalian homologues of LPD-3 in regulating lipid trafficking and lipogenesis also raise the possibility of targeting KIAA1109/BLTP1 in diverse lipid metabolic disorders, including fatty liver diseases and obesity. Here, BLTP1 is linked to fatty liver disease.